Form D · Pharmaceuticals

Madeira Therapeutics, LLC

Leawood, KS · CIK 0001482275

Offering snapshot reported Apr 13, 2011 · SEC filing

Reported sold
$420K
Offering amount: $2.03M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 1, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$210K$420KApr 13, 2010: $90,000.00Apr 13, 2010Apr 13, 2011: $420,000.00Apr 13, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$90,000 → $420,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 13, 2011Amendment$420,000$330,000vs Apr 13, 20103SEC filing
Apr 13, 2010Initial$90,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$30K (estimated)
Form D file number
021-140467

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
David WollNone

Source: Form D, filed Apr 13, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Camargo Pharmaceutical Services, Llc Promoter
Craig L. Chance Executive
Peter R. Joiner Executive, Promoter
Kenneth V. Phelps Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4745 W. 136 Th Street Suite 102
Leawood, KS, 66224